Abivax S.A. (ABVX)
NASDAQ: ABVX
· Real-Time Price · USD
71.89
2.93 (4.25%)
At close: Aug 20, 2025, 3:59 PM
71.15
-1.03%
Pre-market: Aug 21, 2025, 06:45 AM EDT
Abivax S.A. Balance Sheet Statement
Financials in EUR. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Cash & Equivalents | 144.22M | 222.32M | 251.94M | 114.38M | 26.94M | 11.56M | 60.7M | 4.34M |
Short-Term Investments | 136K | n/a | 9.05M | -1.13M | 6K | 15.01M | 6K | 6K |
Long-Term Investments | n/a | n/a | 124K | 1.19M | 71K | -11.19M | 214K | 1.53M |
Other Long-Term Assets | 6.87M | 13.91M | 15.07M | 15.48M | -2K | -1K | 2.75M | 6K |
Receivables | 15.66M | n/a | 19.1M | 12.7M | 8.32M | 11.03M | 8.34M | 12.73M |
Inventory | n/a | n/a | n/a | n/a | 12.19M | n/a | 4M | n/a |
Other Current Assets | 7.42M | 17.72M | -1K | n/a | -682K | n/a | n/a | n/a |
Total Current Assets | 170.67M | 242.99M | 285.97M | 130.37M | 36.18M | 43.84M | 75.21M | 21.38M |
Property-Plant & Equipment | 2.67M | 2.57M | 878K | 202K | 323K | 113K | 93K | 79K |
Goodwill & Intangibles | 25.02M | 25.03M | 25.02M | 25.03M | 23.52M | 21.14M | 32.1M | 32.1M |
Total Long-Term Assets | 34.56M | 41.51M | 41.09M | 40.71M | 39.36M | 27.8M | 35.15M | 33.72M |
Total Assets | 205.23M | 284.49M | 327.06M | 171.08M | 75.54M | 71.64M | 109.23M | 55.09M |
Account Payables | 43.82M | 30.55M | 47.22M | 15.31M | 15.47M | 14.46M | 18.56M | 18.87M |
Deferred Revenue | n/a | n/a | 52K | 121K | 133K | n/a | 162K | n/a |
Short-Term Debt | 42.84M | 37.56M | 30.88M | 12.12M | 29.49M | 14K | 10.06M | 26.82M |
Other Current Liabilities | 1.88M | 5.67M | 3.51M | 4.58M | 2.87M | n/a | -385K | n/a |
Total Current Liabilities | 94M | 79.97M | 88.11M | 46.21M | 51.46M | 16.65M | 32.26M | 47.69M |
Long-Term Debt | 64.02M | 73.58M | 26.62M | 24.47M | 14.84M | 48.84M | 40.27M | 5M |
Other Long-Term Liabilities | 5.2M | 2.8M | 16.15M | 19.35M | n/a | 65K | 10.37M | 32K |
Total Long-Term Liabilities | 70.64M | 78.06M | 42.94M | 44.38M | 16.89M | 48.91M | 51.03M | 5.03M |
Total Liabilities | 164.64M | 158.02M | 131.05M | 90.59M | 68.36M | 65.56M | 83.3M | 52.72M |
Total Debt | 109.22M | 113.36M | 58.04M | 34.69M | 49.23M | 48.86M | 51.65M | 31.82M |
Common Stock | 633K | 629K | 629K | 425K | 223K | 168K | 168K | 147K |
Retained Earnings | -438.88M | -353.1M | -282.95M | -51.95M | -143.51M | -108.46M | -81.81M | -16.53M |
Comprehensive Income | -75K | 33K | 112K | 3K | n/a | 24K | 1K | 7.12M |
Shareholders Equity | 40.58M | 126.47M | 196.01M | 80.49M | 7.19M | 6.08M | 25.93M | 2.37M |
Total Investments | 136K | n/a | 9.19M | 56K | 77K | 3.82M | 220K | 1.54M |